Brookline Capital Reiterates Adial Pharmaceuticals (ADIL) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on July 11, 2023, Brookline Capital reiterated coverage of Adial Pharmaceuticals (NASDAQ:ADIL) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1336655800-0cde652f461b4771aa45601032b5420b.jpg "Home Equity Loans and Divorce")
:max_bytes(150000):strip_icc():format(jpeg)/WhatIstheThree-YearRuleAug.262021-09d1295e78a743ecac4a31c6c042d52d.jpg "Reverse Mortgage Income Requirements")
:max_bytes(150000):strip_icc():format(jpeg)/flower-box-porch-railing-Getty-Images-Perry-Mastrovito-daaafffb11ed46d0ae9c9bf46b0a4a44.jpg "Interest Rates for Reverse Mortgages")
